In CRC, SREBP1 upregulates FASN, ACACA, and SCD1 to drive fatty acid synthesis, whereas SREBP2 activates HMGCR and HMGCS1 to promote cholesterol biosynthesis. The gene discussed is SCD; the disease is colorectal carcinoma.